In addition, recovery of the normal level of TSP-1 by treatment with recombinant TSP-1 protein could attenuate Aβ-induced dendritic spine loss and synaptic dysfunction in vitro and in vivo, implying a possible role for TSP-1 in AD therapeutics18. The gene discussed is THBS1; the disease is Alzheimer disease.